Publications
100
Citations
6,280
Est. group size
—
Recurring co-author estimate
Active years
22
Publishing since 2005
Ravi K. Patel's research focuses on how the human immune system responds to infections and disease, using large-scale molecular profiling (multiomics, single-cell sequencing) to study conditions like COVID-19, chronic hepatitis B, ulcerative colitis, and cancer. Much of the work examines immune cell behavior (such as T cells) and microbiome interactions to understand disease severity, long-term outcomes, and treatment response. This research combines clinical studies with advanced laboratory and computational techniques to identify patterns that could inform future diagnostics or therapies.
Publication output was relatively steady at 5-7 papers per year from 2017-2022, then increased sharply to a peak of 18 in 2023 before gradually declining toward 2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Clinical cure of chronic hepatitis B is associated with priming and perpetuation of hepatic CD4 <sup>+</sup> T cell responses
Science Translational Medicine · 2026
- Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors
Communications Medicine · 2026
- Immune-microbiome coordination defines interferon setpoints in healthy humans
Cell · 2026
- Congenital cytomegalovirus infection drives oligoclonal expansion of cytotoxic γδ T cells from early fetal progenitors
The Journal of Immunology · 2026
- Regenerative Medicine in Acute and Chronic Lung Disease
Stem cell biology and regenerative medicine · 2026
- Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients
Nature Communications · 2025
- Circulating endothelial signatures correlate with worse outcomes in COVID-19, respiratory failure and ARDS
Critical Care · 2025
- Single-cell RNA sequencing of peripheral blood defines two immunological subtypes of Sjögren’s disease
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Barriers and facilitators to documenting social needs in electronic health records: a pilot survey
Information Research an international electronic journal · 2025
- Ultrasensitive ctDNA monitoring during CDK4/6 inhibitor therapy for metastatic breast cancer.
Journal of Clinical Oncology · 2025
- Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment
PLoS ONE · 2025
- Clinical cure of chronic hepatitis B is dependent on activation and perpetuation of robust CD4 <sup>+</sup> T cell responses
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study
Nature Communications · 2024
- Single-cell and spatial multi-omics highlight effects of anti-integrin therapy across cellular compartments in ulcerative colitis
Nature Communications · 2024
- The gene regulatory basis of bystander activation in CD8 <sup>+</sup> T cells
Science Immunology · 2024
- bioRxiv (Cold Spring Harbor Laboratory)×13
- Nature Communications×6
- The Journal of Immunology×3
- Research Square×3
- Blood×3
- Peng Wang
Medicine · The Ohio State University
- Ramasamy Santhanam
Medicine · The Ohio State University
- Parvathi Ranganathan
Medicine · The Ohio State University
- Alexander Rudich
Medicine · The Ohio State University
- Allyson Waller
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile